These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 39422661)

  • 1. Integrative study of skeletal muscle mitochondrial dysfunction in a murine pancreatic cancer-induced cachexia model.
    Gicquel T; Marchiano F; Reyes-Castellanos G; Audebert S; Camoin L; Habermann BH; Giannesini B; Carrier A
    Elife; 2024 Oct; 13():. PubMed ID: 39422661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEF2c-Dependent Downregulation of Myocilin Mediates Cancer-Induced Muscle Wasting and Associates with Cachexia in Patients with Cancer.
    Judge SM; Deyhle MR; Neyroud D; Nosacka RL; D'Lugos AC; Cameron ME; Vohra RS; Smuder AJ; Roberts BM; Callaway CS; Underwood PW; Chrzanowski SM; Batra A; Murphy ME; Heaven JD; Walter GA; Trevino JG; Judge AR
    Cancer Res; 2020 May; 80(9):1861-1874. PubMed ID: 32132110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin.
    Zhong X; Narasimhan A; Silverman LM; Young AR; Shahda S; Liu S; Wan J; Liu Y; Koniaris LG; Zimmers TA
    J Cachexia Sarcopenia Muscle; 2022 Aug; 13(4):2146-2161. PubMed ID: 35510530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic signal transducer and activator of transcription-3 signalling drives early-stage pancreatic cancer cachexia via suppressed ketogenesis.
    Arneson-Wissink PC; Mendez H; Pelz K; Dickie J; Bartlett AQ; Worley BL; Krasnow SM; Eil R; Grossberg AJ
    J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):975-988. PubMed ID: 38632714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased skeletal muscle intramyocellular lipid droplet-mitochondrial contact contributes to myosteatosis in cancer cachexia.
    Cardaci TD; VanderVeen BN; Huss AR; Bullard BM; Velázquez KT; Frizzell N; Carson JA; Price RL; Murphy EA
    Am J Physiol Cell Physiol; 2024 Sep; 327(3):C684-C697. PubMed ID: 39010842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation and Wasting of Skeletal Muscles in Kras-p53-Mutant Mice with Intraepithelial Neoplasia and Pancreatic Cancer-When Does Cachexia Start?
    Hildebrandt W; Keck J; Schmich S; Bonaterra GA; Wilhelm B; Schwarzbach H; Eva A; Bertoune M; Slater EP; Fendrich V; Kinscherf R
    Cells; 2022 May; 11(10):. PubMed ID: 35626644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy.
    Zhong X; Pons M; Poirier C; Jiang Y; Liu J; Sandusky GE; Shahda S; Nakeeb A; Schmidt CM; House MG; Ceppa EP; Zyromski NJ; Liu Y; Jiang G; Couch ME; Koniaris LG; Zimmers TA
    J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1083-1101. PubMed ID: 31286691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle oxidative capacity during IL-6-dependent cancer cachexia.
    White JP; Baltgalvis KA; Puppa MJ; Sato S; Baynes JW; Carson JA
    Am J Physiol Regul Integr Comp Physiol; 2011 Feb; 300(2):R201-11. PubMed ID: 21148472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia.
    Rupert JE; Narasimhan A; Jengelley DHA; Jiang Y; Liu J; Au E; Silverman LM; Sandusky G; Bonetto A; Cao S; Lu X; O'Connell TM; Liu Y; Koniaris LG; Zimmers TA
    J Exp Med; 2021 Jun; 218(6):. PubMed ID: 33851955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mitochondrial metabolic reprogramming agent trimetazidine as an 'exercise mimetic' in cachectic C26-bearing mice.
    Molinari F; Pin F; Gorini S; Chiandotto S; Pontecorvo L; Penna F; Rizzuto E; Pisu S; Musarò A; Costelli P; Rosano G; Ferraro E
    J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):954-973. PubMed ID: 29130633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling Human Cancer-induced Cachexia.
    Talbert EE; Cuitiño MC; Ladner KJ; Rajasekerea PV; Siebert M; Shakya R; Leone GW; Ostrowski MC; Paleo B; Weisleder N; Reiser PJ; Webb A; Timmers CD; Eiferman DS; Evans DC; Dillhoff ME; Schmidt CR; Guttridge DC
    Cell Rep; 2019 Aug; 28(6):1612-1622.e4. PubMed ID: 31390573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lcn2 mediates adipocyte-muscle-tumor communication and hypothermia in pancreatic cancer cachexia.
    Lemecha M; Chalise JP; Takamuku Y; Zhang G; Yamakawa T; Larson G; Itakura K
    Mol Metab; 2022 Dec; 66():101612. PubMed ID: 36243318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and Physiological Evaluation of Pancreatic Cancer-Induced Cachexia.
    Shukla SK; Dasgupta A; Mulder SE; Singh PK
    Methods Mol Biol; 2019; 1882():321-333. PubMed ID: 30378066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of a mouse model of pancreatic cancer to simulate the human phenotypes of metastasis and cachexia.
    Spadafora V; Pryce BR; Oles A; Talbert EE; Romeo M; Vaena S; Berto S; Ostrowski MC; Wang DJ; Guttridge DC
    BMC Cancer; 2024 Apr; 24(1):414. PubMed ID: 38570770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct cachexia profiles in response to human pancreatic tumours in mouse limb and respiratory muscle.
    Nosacka RL; Delitto AE; Delitto D; Patel R; Judge SM; Trevino JG; Judge AR
    J Cachexia Sarcopenia Muscle; 2020 Jun; 11(3):820-837. PubMed ID: 32039571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle weakness and mitochondrial stress occur before severe metastasis in a novel mouse model of ovarian cancer cachexia.
    Delfinis LJ; Ogilvie LM; Khajehzadehshoushtar S; Gandhi S; Garibotti MC; Thuhan AK; Matuszewska K; Pereira M; Jones RG; Cheng AJ; Hawke TJ; Greene NP; Murach KA; Simpson JA; Petrik J; Perry CGR
    Mol Metab; 2024 Aug; 86():101976. PubMed ID: 38925248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation-associated intramyocellular lipid alterations in human pancreatic cancer cachexia.
    Deng M; Cao J; van der Kroft G; van Dijk DPJ; Aberle MR; Grgic A; Neumann UP; Wiltberger G; Balluff B; Schaap FG; Heeren RMA; Olde Damink SWM; Rensen SS
    J Cachexia Sarcopenia Muscle; 2024 Aug; 15(4):1283-1297. PubMed ID: 38725139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: a systematic review.
    Ozola Zalite I; Zykus R; Francisco Gonzalez M; Saygili F; Pukitis A; Gaujoux S; Charnley RM; Lyadov V
    Pancreatology; 2015; 15(1):19-24. PubMed ID: 25524484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer.
    Burfeind KG; Zhu X; Norgard MA; Levasseur PR; Huisman C; Buenafe AC; Olson B; Michaelis KA; Torres ER; Jeng S; McWeeney S; Raber J; Marks DL
    Elife; 2020 May; 9():. PubMed ID: 32391790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Pancreatic Cancer-Induced Cachexia Using a Fluorescent Myoblast Reporter System and Analysis of Metabolite Abundance.
    Winnard PT; Bharti SK; Penet MF; Marik R; Mironchik Y; Wildes F; Maitra A; Bhujwalla ZM
    Cancer Res; 2016 Mar; 76(6):1441-50. PubMed ID: 26719527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.